4d pharma PLC (LSE:DDDD) - Share price - Overview

Stock Report

4d pharma PLC DDDD

Last Price
GBX436.88

Day Change
-8.13|-1.83%

As of 28/03/2017
16:31:32 BST | GBX
Minimum 15 Minutes Delay.

Last Close445.00p
Day Range425.50 - 458.51
Mkt Cap288.60Mil
52-Wk Range420.81 - 1,001.25
Yield %0.00
ISINGB00BJL5BR07
Volume4,800
P/E-34.63
P/SInfinity
P/CF-29.36

Share Price

Total Returns 28/03/2017

 Chg (%)  
More ...
4d pharma PLC-33.81 
FTSE 100 TR GBP1.34
 
Financials
201320142015
More ...
Income Statement
Turnover-0.000.00
Operating Profit--3.56-10.51
Net Profit--2.44-7.73
Reported EPS--4.93-12.62
Balance Sheet
Current Assets-32.5490.11
Non Current Assets-6.687.29
Total Assets-39.2297.39
Current Liabilities-1.794.31
Total Liabilities-2.174.69
Total Equity-37.0592.70
Cash Flow
Operating Cash Flow--3.92-9.07
Net Change in Cash-29.55-27.05
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
--------
--------

Regulatory News

DateSourceHeadline
More ...
10/03/2017|16:37RNS4d Pharma PLC - Holding(s) in Company
06/03/2017|07:00RNS4d Pharma PLC - Clinical Update
13/12/2016|07:00RNS4d Pharma PLC - Clinical Update

Company Profile

4d pharma PLC is a pharmaceutical company focusing on new therapeutic areas known as live biotherapeutics.

Sector

Biotechnology

Market Position

593 of 1851 Companies

Index

FTSE AIM UK 50 ,FTSE AIM 100 ,FTSE AIM All Share

Outlook

(30/09/2016) no outlook statement

Next Event 31/03/2017

Next prelim announcement
Ratios
CompSecMkt
More ...
PER (E)0.0014.5616.20
Div Yld (E)0.003.654.14
PEG (E)0.000.301.00
ROCE-11.57180.98121.43
Op Mrgn0.00-10.94-8.93
EPS Grwth0.0084.4835.80
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00

Broker Sentiment

Strong Buy0
Buy0
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanRobert Norwood
Chief Executive OfficerDuncan Peyton
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.